Article · 2022
Editorial Board Member
Dr Sergey Suchkov
Professor, Department of Clinical Immunology, A.I.Evdokimov Moscow State University of Medicine, Russia
About
As published by the journal they serve.
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology, USSR Academy of Medical Sciences. In 2001, maintained his Doctor Degree at the National Institute of Immunology, Russia. From 1985 through 1987, worked as a Post Doc Research Associate, for Institute of Medical Enzymology; from 1987 through 1989, was a Senior Research Associate, Koltzov Institute of Developmental Biology, USSR Academy of Sciences. From 1989 through 1995, was a Head of the Lab of Immunology and Immunobiotechnology, Helmholtz Eye Research Institute in Moscow. In 1989, trained at the Lab of Immunology, NEI, Bethesda, MD, USA, NIH and Lab of Immunology, Wills Eye Hospital, Philadelphia, USA, as well as at some of the British Universities on the invitation of the Royal Society for Immunology. From 1995 through 2004, was a Director of the Dept for Immunology, Moscow Clinical Research Institute (MONIKI). In 1993-1996, was an Executice Secretary-in-Chief of the Editorial Board, Biomedical Science, an international journal published jointly by the USSR Academy of Sciences and the Royal Society of Chemistry, UK.
Research interests
Journals they serve
The seats these journals name them in.
- La Prensa MedicaEditorial Board Member
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2022
Personalized and Precision Medicine (PPM) as a Unique Healthcare Model to Be Set Up through Biodesign, Unique Translational Applications and Upgraded Business Marketing to Secure the Human Healthcare, Wellness and Biosafety
Article · 2021
Personalized and Precision Medicine (PPM) as a Unique Healthcare Model to Be Set Up via Translational Applications and Upgraded Business Modeling to Secure the Human Healthcare, Wellness and Biosafety
Article · 2019
Antibodies with functionality as a new generation of translational tools designed to be programmed via translational resources to predict and to prevent demyelination
Article · 2018
Personalized and translational medicine as a model of the healthcare services and ar-mamentarium to get the model armed: Myth or the reality?
Article · 2018
Antibody-proteases as a novel biomarker and a unique target to suit translational tools to be applied for biodesign and bioengineering
Article · 2018
Antibody-proteases as a novel biomarker and a unique target to be applied for biodesign and bioengineering
Article · 2018
Personalized and Precision Medicine as a model of healthcare of the newest generation towards translational applications to move ahead as a Global International Team
Article · 2018
Personalized and Precision Medicine (PPM) as a model of healthcare of the newest generation towards translational applications to move ahead as a global international team
Article · 2017
Personalized healthcare services and innovative tools to manage chronic disorders and cardiac failures and to secure health
Article · 2017
Personalized healthcare services and innovative tools to manage chronic disorders and cardiac failures and to secure health
Article · 2017
Antibodies with functionality as a new generation of translational tools to monitor, predict and prevent demyelination
Article · 2017
Antibody-proteases as a novel biomarker and a unique target to manage demyelination: A new way for drug design and drug discovery
Article · 2016
PPPM (Predictive, Preventive and Personalized Medicine) as a novel avenue and a source of new translational tools to predict and to prevent chronic autoimmune disorders
Article · 2015
Antibody-proteases as promising tools of novel generation to be translated into clinical practice for having multistep (subclinical and clinical) demyelination monitoring secured
Article · 2015
Post-Infectious Autoimmune Syndrome (PIFAS) as an integrated and combinatorial biomarker to monitor autoimmune myocarditis and thus the chronification of post-infectious diseases of autoimmune origin
Article · 2015
Antibody-proteases as promising tools of novel generation to be translated into clinical practice for having multistep (subclinical and clinical) demyelination monitoring secured
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.